Verona Pharma PLC ADR (VRNA) — Working Capital to Net Assets Ratio
Verona Pharma PLC ADR (VRNA) has a Working Capital to Net Assets ratio of 178.8% as of June 2025. Working capital of $497.61 Million (current assets of $548.85 Million minus current liabilities of $51.24 Million) is measured against net assets of $278.27 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of Verona Pharma PLC ADR to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Verona Pharma PLC ADR Working Capital to Net Assets (2005–2024)
This chart shows how Verona Pharma PLC ADR's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2005 to 2024. As of June 2025, the ratio stands at 178.8%, reflecting working capital of $497.61 Million against net assets of $278.27 Million USD. See Verona Pharma PLC ADR (VRNA) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Verona Pharma PLC ADR (2005–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Verona Pharma PLC ADR from 2005 to 2024, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see VRNA market cap.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 200.9% | $410.89 Million | $204.56 Million | $453.57 Million | $42.68 Million | ▲ +88.1 pp |
| 2023 | 112.7% | $281.02 Million | $249.28 Million | $289.71 Million | $8.69 Million | ▲ +15.5 pp |
| 2022 | 97.2% | $223.97 Million | $230.47 Million | $243.00 Million | $19.03 Million | ▲ +4.9 pp |
| 2021 | 92.3% | $136.64 Million | $148.00 Million | $170.06 Million | $33.42 Million | ▼ -9.5 pp |
| 2020 | 101.9% | $188.30 Million | $184.85 Million | $202.50 Million | $14.20 Million | ▲ +9.4 pp |
| 2019 | 92.4% | $41.05 Million | $44.40 Million | $53.66 Million | $12.61 Million | ▼ -5.2 pp |
| 2018 | 97.6% | $77.96 Million | $79.86 Million | $90.94 Million | $12.97 Million | ▼ -0.6 pp |
| 2017 | 98.2% | $106.06 Million | $107.95 Million | $117.68 Million | $11.62 Million | ▲ +2.7 pp |
| 2016 | 95.6% | $40.64 Million | $42.53 Million | $54.05 Million | $13.41 Million | ▲ +28.3 pp |
| 2015 | 67.3% | $5.57 Million | $8.28 Million | $8.26 Million | $2.69 Million | ▼ -17.9 pp |
| 2014 | 85.2% | $16.71 Million | $19.62 Million | $17.52 Million | $816.08K | ▲ +67.5 pp |
| 2013 | 17.6% | $600.41K | $3.41 Million | $1.41 Million | $806.89K | ▼ -19.6 pp |
| 2012 | 37.2% | $1.57 Million | $4.21 Million | $1.89 Million | $322.11K | ▼ -23.5 pp |
| 2011 | 60.8% | $3.82 Million | $6.29 Million | $4.06 Million | $242.21K | ▲ +6.7 pp |
| 2010 | 54.1% | $2.88 Million | $5.33 Million | $3.20 Million | $317.94K | ▼ -11.2 pp |
| 2009 | 65.2% | $4.73 Million | $7.25 Million | $5.19 Million | $464.08K | ▲ +4.2 pp |
| 2008 | 61.1% | $3.57 Million | $5.85 Million | $3.69 Million | $123.01K | ▲ +14.8 pp |
| 2007 | 46.3% | $2.65 Million | $5.73 Million | $2.96 Million | $311.35K | ▼ -14.0 pp |
| 2006 | 60.3% | $4.60 Million | $7.64 Million | $4.73 Million | $129.31K | ▼ -39.7 pp |
| 2005 | 100.0% | $1.68 Million | $1.68 Million | $1.71 Million | $20.65K | — |